BigHat Biosciences
San Francisco, US · 5 known investors
Big Hat Bio develops therapeutics under development across multiple programs. The company is a STEM-focused team working on therapeutic discovery and development.
Investors · 5
In the news
- Revolutionizing Antibody Therapeutics: BigHat Biosciences Secures $75 Million in Funding from Leading Investors | Signalbasetrysignalbase.com · 2024
- BigHat - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2022
- BigHat Biosciences inks $75m Series Bventurecapitaljournal.com · 2022
- BigHat Biosciences Raises USD75M Series B Funding Roundfinsmes.com · 2022
- BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies - BioSpacebiospace.com · 2022
- Creating Better Drugs: BigHat Biosciences Raises $19M Series A For Antibody Platformnews.crunchbase.com · 2021